Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.35 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.35 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.34 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.34 |
| ▸ | G6PD | P11413 | 1/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.34 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13846318 | 0.87 | CYP2D6 (0.35) | KMT2ATSHRCYP2D6LMNAALDH1A1 | |
| SCHEMBL3366770 | 0.86 | TACR1 (0.42) | KMT2ATSHRCYP2D6LMNAALDH1A1 | |
| SCHEMBL4886714 | 0.85 | PABPC1 (0.41) | KMT2ATSHRLMNAPABPC1APOBEC3A | |
| SCHEMBL3369033 | 0.83 | KMT2A (0.45) | KMT2ATSHRCYP2D6LMNAALDH1A1 | |
| SCHEMBL3627121 | 0.82 | GSR (0.38) | KMT2ATSHRCYP2D6LMNA | |
| SCHEMBL25452991 | 0.78 | KMT2A (0.46) | KMT2ATSHRCYP2D6LMNAALDH1A1 | |
| SCHEMBL13008873 | 0.77 | SLC6A2 (0.38) | KMT2ATSHRCYP2D6LMNAMAPT | |
| SCHEMBL12274081 | 0.77 | TSHR (0.47) | KMT2ATSHRCYP2D6LMNAALDH1A1 | |
| SCHEMBL6809943 | 0.74 | KMT2A (0.37) | KMT2ATSHRCYP2D6LMNA | |
| SCHEMBL13211918 | 0.74 | HSD11B1 (0.34) | KMT2ATSHRCYP2D6LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106536588-A | Polyisocyanate composition for producing flexible polyurethane foam, and process for producing flexible polyurethane foam using same | 东曹株式会社 | 2017-03-22 | — | — | CN | claimed |
| CN-102069037-B | Composite hydrocarbon oil molybdenum flotation collecting agent and preparation method thereof | UNIV XI AN ARCHITECTURE & TECH | 2012-09-05 | — | — | CN | claimed |
| CN-102069037-A | Composite hydrocarbon oil molybdenum flotation collecting agent and preparation method thereof | UNIV XI AN ARCHITECTURE & TECH | 2011-05-25 | — | — | CN | claimed |
| CN-102069037-B | Composite hydrocarbon oil molybdenum flotation collecting agent and preparation method thereof | UNIV XI AN ARCHITECTURE & TECH | 2012-09-05 | — | — | CN | disclosed |
| CN-102069037-A | Composite hydrocarbon oil molybdenum flotation collecting agent and preparation method thereof | UNIV XI AN ARCHITECTURE & TECH | 2011-05-25 | — | — | CN | disclosed |
| EP-1284966-B1 | PROCESS FOR THE SYNTHESIS OF AMINE ETHERS FROM SECONDARY AMINO OXIDES | BASF SE (DE) | 2010-03-17 | — | — | EP | disclosed |
| US-7402675-B2 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORP. (US) | 2008-07-22 | — | — | US | disclosed |
| US-6900328-B2 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-05-31 | — | — | US | disclosed |
| US-20050043552-A1 | Process for the synthesis of amine ethers from secondary amino oxides | HAFNER ANDREAS (CH) | 2005-02-24 | — | — | US | disclosed |
| US-20030171461-A1 | Process for the synthesis of amine ethers from secondary amino oxides | CIBA SPECIALTY CHEMICALS CORP. | 2003-09-11 | — | — | US | disclosed |
| EP-1294787-A2 | USE OF LOW UNSATURATED POLYETHER POLYOLS IN SLABSTOCK FOAM APPLICATIONS | BASF CORPORATION (US) | 2003-03-26 | — | — | EP | disclosed |
| EP-1284966-A2 | PROCESS FOR THE SYNTHESIS OF AMINE ETHERS FROM SECONDARY AMINO OXIDES | Ciba SC Holding AG (CH) | 2003-02-26 | — | — | EP | disclosed |
| WO-2001092228-A2 | PROCESS FOR THE SYNTHESIS OF AMINE ETHERS FROM SECONDARY AMINO OXIDES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-12-06 | — | — | WO | disclosed |
| WO-2001090209-A2 | USE OF LOW UNSATURATED POLYETHER POLYOLS IN SLABSTOCK FOAM APPLICATIONS | BASF CORPORATION (US) | 2001-11-29 | — | — | WO | disclosed |
| EP-0868455-A1 | ELASTOMERIC POLYURETHANES WITH IMPROVED PROPERTIES BASED ON CRYSTALLIZABLE POLYOLS IN COMBINATION WITH LOW MONOL POLYOXYPROPYLENE POLYOLS | ARCO Chemical Technology, L.P. (US) | 1998-10-07 | — | — | EP | disclosed |
| WO-1997023531-A1 | ELASTOMERIC POLYURETHANES WITH IMPROVED PROPERTIES BASED ON CRYSTALLIZABLE POLYOLS IN COMBINATION WITH LOW MONOL POLYOXYPROPYLENE POLYOLS | ARCO CHEMICAL TECHNOLOGY, L.P. (US) | 1997-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043552-A1 | Process for the synthesis of amine ethers from secondary amino oxides | CYC1, AOC2, CBR1 | KMT2A 1447/4885TSHR 831/4885CYP2D6 72/4885 |
| US-20030171461-A1 | Process for the synthesis of amine ethers from secondary amino oxides | IL4I1, HCCS, CBR1 | KMT2A 1055/4885TSHR 1905/4885CYP2D6 983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.